authentic networking LinkedIn connections overcoming networking fear building genuine connections networking communication skills altruism in networking networking courage

Be Brave-A Networking Tale that Led to Friendship

by MSL Talk, Tom Caravela, Josh Yoder, Kirsten Borbe
· The Carolan Group

Jun 3^rd 2025
36 mins
E256

Share This Article

Summary

In this episode, Josh Yoder and Kirsten Borbe to share their amazing story of how a networking message on LinkedIn led to a friendship. The discussion begins with insights into Josh and Kirsten's backgrounds and networking perspectives. They emphasize the importance of authentic networking and overcoming fear, sharing strategies for building genuine connections and evolving professional relationships into friendships. Key communication skills such as brevity and authenticity are highlighted, alongside the role of altruism in networking. The conversation addresses the fear of risk and concludes with thoughts on networking courage and bravery. Closing remarks offer appreciation for the insights shared.

Key Points

Networking should be approached with authenticity and a genuine interest in others, rather than self-promotion.
Building meaningful connections often involves taking risks and embracing opportunities, even if it means stepping out of your comfort zone.
The real value in networking comes from helping others without expecting anything in return, which often leads to more fulfilling and long-lasting relationships.

Click for Source

authentic networking, LinkedIn connections, overcoming networking fear, building genuine connections, networking communication skills, altruism in networking, networking courage

Be Brave-A Networking Tale that Led to Friendship

Share This Article

Key Points

Related Topics

Meet Our Innovation Partners

You May Also Like

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Explore OVN